Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:11 pm Purchase | 2024-12-31 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 11,805,301 9.900% | 149,236 (+1.28%) | Filing |
| 2025-02-03 7:43 pm Purchase | 2025-01-30 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 5,012,796 10.100% | 5,012,796 (New Position) | Filing |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 11,656,065 9.990% | 3,778,248 (+47.96%) | Filing |
| 2024-02-14 9:20 pm Purchase | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 7,877,817 9.990% | 2,080,232 (+35.88%) | Filing |
| 2023-05-08 4:05 pm Purchase | 2023-04-26 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 5,797,585 9.990% | 5,797,585 (New Position) | Filing |